기억력 향상제 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측, 약제 클래스별, 투여 경로별, 유통 채널별, 지역별, 경쟁별(2020-2030년)
Memory Enhancement Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class, By Route of Administration, By Distribution Channel, By Region and Competition, 2020-2030F
상품코드:1667889
리서치사:TechSci Research
발행일:2025년 02월
페이지 정보:영문 183 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계 기억력 향상제 시장은 2024년 73억 2,000만 달러로 평가되었고, 예측 기간 동안 연평균 5.21%의 연평균 복합 성장률(CAGR)로 성장하여 2030년에는 99억 5,000만 달러에 달할 것으로 예상됩니다.
이 시장은 광범위한 인지 건강 및 신경학 부문의 일부분으로, 주로 기억력, 인지 기능 및 전반적인 뇌 건강을 개선하기 위한 의약품 및 보충제에 초점을 맞추었습니다. 시장 성장의 배경에는 인지 장애의 유병률 증가, 인구 고령화, 인지 기능 향상에 대한 관심 증가 등이 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
73억 2,000만 달러
시장 규모 : 2030년
99억 5,000만 달러
CAGR(2025-2030년)
5.21%
급성장 부문
콜린에스테라아제 억제제
최대 시장
북미
시장 성장 촉진요인
1. 인구 고령화
주요 시장 과제
1. 규제와 안전에 대한 우려
주요 시장 동향
1. 인지 건강 및 웰빙에 대한 관심 증가
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 기억력 향상제 시장 전망
시장 규모와 예측
금액별
시장 점유율과 예측
약제 클래스별(콜린에스테라제 억제제, 스마트 약물 및 인지 기능 향상제, 비타민 및 보충제, 기타)
투여 경로별(경구, 주사, 국소)
유통 채널별(병원 약국, 소매 약국, 온라인 약국)
지역별
기업별(2024년)
시장 맵
제6장 북미의 기억력 향상제 시장 전망
시장 규모와 예측
시장 점유율과 예측
북미 : 국가별 분석
캐나다
멕시코
제7장 유럽의 기억력 향상제 시장 전망
시장 규모와 예측
시장 점유율과 예측
유럽 : 국가별 분석
영국
이탈리아
프랑스
스페인
제8장 아시아태평양의 기억력 향상제 시장 전망
시장 규모와 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
인도
일본
한국
호주
제9장 남미의 기억력 향상제 시장 전망
시장 규모와 예측
시장 점유율과 예측
남미 : 국가별 분석
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 기억력 향상제 시장 전망
시장 규모와 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병(M&A)(해당하는 경우)
제품 발매(해당하는 경우)
제13장 Porter의 Five Forces 분석
산업내 경쟁
신규 참여 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제14장 경쟁 구도
Pfizer Inc.
UCB S.A.
Takeda Pharmaceutical Company Limited
SANOCHEMIA Pharmazeutika GmbH
AbbVie Inc.
Novartis AG
Alkem Laboratories Ltd.
Intas Pharmaceutical Ltd.
Novartis AG
Otsuka Holdings Co., Ltd.
제15장 전략적 제안
제16장 리서치사에 대해 & 면책사항
LSH
영문 목차
영문목차
The global Memory Enhancement Drugs Market was valued at USD 7.32 billion in 2024 and is projected to reach USD 9.95 billion by 2030, growing at a compound annual growth rate (CAGR) of 5.21% during the forecast period. This market is a subset of the broader cognitive health and neurology sectors, primarily focusing on pharmaceuticals and supplements aimed at improving memory, cognitive function, and overall brain health. The market's expansion is driven by the rising prevalence of cognitive disorders, an aging population, and a growing focus on cognitive well-being.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 7.32 Billion
Market Size 2030
USD 9.95 Billion
CAGR 2025-2030
5.21%
Fastest Growing Segment
Cholinesterase Inhibitors
Largest Market
North America
Key Market Drivers
1. Aging Population
The aging global population is a significant driver in the memory enhancement drugs market. As individuals age, they become more susceptible to cognitive decline and neurodegenerative diseases such as Alzheimer's and dementia, increasing the demand for memory-enhancing solutions.
Rising Proportion of Elderly: The demographic shift toward an aging population is a key factor propelling the demand for memory enhancement drugs. This shift is attributed to lower birth rates and higher life expectancy. According to the World Health Organization, by 2050, the global population aged 60 and above is expected to double to 2.1 billion, with the number of people aged 80 and older tripling from 2020 to 2050, reaching 426 million.
Key Market Challenges
1. Regulatory and Safety Concerns
A significant challenge facing the market is the lack of sufficient scientific evidence supporting the long-term safety and efficacy of many memory enhancement drugs. Numerous products, especially those marketed as over-the-counter supplements or off-label drugs, do not undergo rigorous clinical trials to validate their claims.
Regulatory Gaps: In many regions, inadequate regulation allows certain products to enter the market without comprehensive testing or quality control. This exposes consumers to potential risks from ineffective or harmful substances. The lack of sufficient regulation also results in insufficient consumer awareness regarding potential risks, leading to misuse or adverse effects.
Key Market Trends
1. Growing Focus on Cognitive Health and Wellness
There is a noticeable shift towards preventive healthcare, with an increasing emphasis on maintaining cognitive health throughout life. As people become more aware of the importance of cognitive function for overall well-being, they are actively seeking ways to optimize memory, mental clarity, and brain health at all stages of life. This shift has led to greater interest in both traditional and innovative methods for enhancing cognitive performance.
A 2021 study involving 44 healthy participants aged 18 to 36 showed that those who took prucalopride performed significantly better in memory tests compared to a placebo group. Functional MRI scans revealed enhanced brain activity, particularly in regions related to memory, including the hippocampus and the right angular gyrus.
Key Market Players
Pfizer Inc.
UCB S.A.
Takeda Pharmaceutical Company Limited
SANOCHEMIA Pharmazeutika GmbH
AbbVie Inc.
Novartis AG
Alkem Laboratories Ltd.
Intas Pharmaceutical Ltd.
Otsuka Holdings Co., Ltd.
Market Segmentation
The Global Memory Enhancement Drugs Market is segmented as follows:
1. By Drug Class
Cholinesterase Inhibitors
Smart Drugs and Cognitive Enhancers
Vitamins and Supplements
Others
2. By Route of Administration
Oral
Injectable
Topical
3. By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
4. By Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
South Korea
Australia
Japan
Europe
Germany
France
United Kingdom
Spain
Italy
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
The report provides detailed analysis of the major players in the global Memory Enhancement Drugs Market.
Available Customizations
TechSci Research offers customization options for this report, including the following:
Company Information: In-depth profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Memory Enhancement Drugs Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Drug Class (Cholinesterase Inhibitors, Smart Drugs and Cognitive Enhancers, Vitamins and Supplements, Others)
5.2.2. By Route of Administration (Oral, Injectable, Topical)
5.2.3. By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
5.2.4. By Region
5.2.5. By Company (2024)
5.3. Market Map
6. North America Memory Enhancement Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Class
6.2.2. By Route of Administration
6.2.3. By Distribution Channel
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Memory Enhancement Drugs Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Drug Class
6.3.1.2.2. By Route of Administration
6.3.1.2.3. By Distribution Channel
6.3.2. Canada Memory Enhancement Drugs Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Drug Class
6.3.2.2.2. By Route of Administration
6.3.2.2.3. By Distribution Channel
6.3.3. Mexico Memory Enhancement Drugs Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Drug Class
6.3.3.2.2. By Route of Administration
6.3.3.2.3. By Distribution Channel
7. Europe Memory Enhancement Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Drug Class
7.2.2. By Route of Administration
7.2.3. By Distribution Channel
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Memory Enhancement Drugs Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Drug Class
7.3.1.2.2. By Route of Administration
7.3.1.2.3. By Distribution Channel
7.3.2. United Kingdom Memory Enhancement Drugs Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Drug Class
7.3.2.2.2. By Route of Administration
7.3.2.2.3. By Distribution Channel
7.3.3. Italy Memory Enhancement Drugs Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Drug Class
7.3.3.2.2. By Route of Administration
7.3.3.2.3. By Distribution Channel
7.3.4. France Memory Enhancement Drugs Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Drug Class
7.3.4.2.2. By Route of Administration
7.3.4.2.3. By Distribution Channel
7.3.5. Spain Memory Enhancement Drugs Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Drug Class
7.3.5.2.2. By Route of Administration
7.3.5.2.3. By Distribution Channel
8. Asia-Pacific Memory Enhancement Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Drug Class
8.2.2. By Route of Administration
8.2.3. By Distribution Channel
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Memory Enhancement Drugs Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Drug Class
8.3.1.2.2. By Route of Administration
8.3.1.2.3. By Distribution Channel
8.3.2. India Memory Enhancement Drugs Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Drug Class
8.3.2.2.2. By Route of Administration
8.3.2.2.3. By Distribution Channel
8.3.3. Japan Memory Enhancement Drugs Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Drug Class
8.3.3.2.2. By Route of Administration
8.3.3.2.3. By Distribution Channel
8.3.4. South Korea Memory Enhancement Drugs Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Drug Class
8.3.4.2.2. By Route of Administration
8.3.4.2.3. By Distribution Channel
8.3.5. Australia Memory Enhancement Drugs Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Drug Class
8.3.5.2.2. By Route of Administration
8.3.5.2.3. By Distribution Channel
9. South America Memory Enhancement Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Drug Class
9.2.2. By Route of Administration
9.2.3. By Distribution Channel
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Memory Enhancement Drugs Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Drug Class
9.3.1.2.2. By Route of Administration
9.3.1.2.3. By Distribution Channel
9.3.2. Argentina Memory Enhancement Drugs Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Drug Class
9.3.2.2.2. By Route of Administration
9.3.2.2.3. By Distribution Channel
9.3.3. Colombia Memory Enhancement Drugs Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Drug Class
9.3.3.2.2. By Route of Administration
9.3.3.2.3. By Distribution Channel
10. Middle East and Africa Memory Enhancement Drugs Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Drug Class
10.2.2. By Route of Administration
10.2.3. By Distribution Channel
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Memory Enhancement Drugs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Drug Class
10.3.1.2.2. By Route of Administration
10.3.1.2.3. By Distribution Channel
10.3.2. Saudi Arabia Memory Enhancement Drugs Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Drug Class
10.3.2.2.2. By Route of Administration
10.3.2.2.3. By Distribution Channel
10.3.3. UAE Memory Enhancement Drugs Market Outlook
